238 related articles for article (PubMed ID: 29440260)
1. Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors.
Chai M; Sanosaka T; Okuno H; Zhou Z; Koya I; Banno S; Andoh-Noda T; Tabata Y; Shimamura R; Hayashi T; Ebisawa M; Sasagawa Y; Nikaido I; Okano H; Kohyama J
Genes Dev; 2018 Jan; 32(2):165-180. PubMed ID: 29440260
[TBL] [Abstract][Full Text] [Related]
2. Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells.
Sanosaka T; Okuno H; Mizota N; Andoh-Noda T; Sato M; Tomooka R; Banno S; Kohyama J; Okano H
Sci Rep; 2022 Dec; 12(1):22648. PubMed ID: 36587182
[TBL] [Abstract][Full Text] [Related]
3. CHD7 cooperates with PBAF to control multipotent neural crest formation.
Bajpai R; Chen DA; Rada-Iglesias A; Zhang J; Xiong Y; Helms J; Chang CP; Zhao Y; Swigut T; Wysocka J
Nature; 2010 Feb; 463(7283):958-62. PubMed ID: 20130577
[TBL] [Abstract][Full Text] [Related]
4. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
[TBL] [Abstract][Full Text] [Related]
5. CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum.
Reddy NC; Majidi SP; Kong L; Nemera M; Ferguson CJ; Moore M; Goncalves TM; Liu HK; Fitzpatrick JAJ; Zhao G; Yamada T; Bonni A; Gabel HW
Nat Commun; 2021 Sep; 12(1):5702. PubMed ID: 34588434
[TBL] [Abstract][Full Text] [Related]
6. CHARGEd with neural crest defects.
Pauli S; Bajpai R; Borchers A
Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):478-486. PubMed ID: 29082625
[TBL] [Abstract][Full Text] [Related]
7. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.
Schnetz MP; Bartels CF; Shastri K; Balasubramanian D; Zentner GE; Balaji R; Zhang X; Song L; Wang Z; Laframboise T; Crawford GE; Scacheri PC
Genome Res; 2009 Apr; 19(4):590-601. PubMed ID: 19251738
[TBL] [Abstract][Full Text] [Related]
8. Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome.
Liu ZZ; Guo J; Lu Y; Liu W; Fu X; Yao T; Zhou Y; Xu HA
Int J Exp Pathol; 2019 Aug; 100(4):234-243. PubMed ID: 31464029
[TBL] [Abstract][Full Text] [Related]
9. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations.
Okuno H; Renault Mihara F; Ohta S; Fukuda K; Kurosawa K; Akamatsu W; Sanosaka T; Kohyama J; Hayashi K; Nakajima K; Takahashi T; Wysocka J; Kosaki K; Okano H
Elife; 2017 Nov; 6():. PubMed ID: 29179815
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome.
Balow SA; Pierce LX; Zentner GE; Conrad PA; Davis S; Sabaawy HE; McDermott BM; Scacheri PC
Dev Biol; 2013 Oct; 382(1):57-69. PubMed ID: 23920116
[TBL] [Abstract][Full Text] [Related]
11. Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination.
He D; Marie C; Zhao C; Kim B; Wang J; Deng Y; Clavairoly A; Frah M; Wang H; He X; Hmidan H; Jones BV; Witte D; Zalc B; Zhou X; Choo DI; Martin DM; Parras C; Lu QR
Nat Neurosci; 2016 May; 19(5):678-689. PubMed ID: 26928066
[TBL] [Abstract][Full Text] [Related]
12. CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.
Schulz Y; Wehner P; Opitz L; Salinas-Riester G; Bongers EM; van Ravenswaaij-Arts CM; Wincent J; Schoumans J; Kohlhase J; Borchers A; Pauli S
Hum Genet; 2014 Aug; 133(8):997-1009. PubMed ID: 24728844
[TBL] [Abstract][Full Text] [Related]
13. Roles of chromatin remodelers in maintenance mechanisms of multipotency of mouse trunk neural crest cells in the formation of neural crest-derived stem cells.
Fujita K; Ogawa R; Kawawaki S; Ito K
Mech Dev; 2014 Aug; 133():126-45. PubMed ID: 24836203
[TBL] [Abstract][Full Text] [Related]
14. CHD7 promotes neural progenitor differentiation in embryonic stem cells via altered chromatin accessibility and nascent gene expression.
Yao H; Hannum DF; Zhai Y; Hill SF; Albanus RD'; Lou W; Skidmore JM; Sanchez G; Saiakhova A; Bielas SL; Scacheri P; Ljungman M; Parker SCJ; Martin DM
Sci Rep; 2020 Oct; 10(1):17445. PubMed ID: 33060836
[TBL] [Abstract][Full Text] [Related]
15. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
[No Abstract] [Full Text] [Related]
16. CHD7, Oct3/4, Sox2, and Nanog control FoxD3 expression during mouse neural crest-derived stem cell formation.
Fujita K; Ogawa R; Ito K
FEBS J; 2016 Oct; 283(20):3791-3806. PubMed ID: 27579714
[TBL] [Abstract][Full Text] [Related]
17. The chromatin remodeler CHD7 regulates adult neurogenesis via activation of SoxC transcription factors.
Feng W; Khan MA; Bellvis P; Zhu Z; Bernhardt O; Herold-Mende C; Liu HK
Cell Stem Cell; 2013 Jul; 13(1):62-72. PubMed ID: 23827709
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular effects of CHD7 in the heart.
Corsten-Janssen N; Scambler PJ
Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):487-495. PubMed ID: 29088513
[TBL] [Abstract][Full Text] [Related]
19. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome.
Basson MA; van Ravenswaaij-Arts C
Trends Genet; 2015 Oct; 31(10):600-611. PubMed ID: 26411921
[TBL] [Abstract][Full Text] [Related]
20. CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression.
Stathopoulou A; Wang P; Thellier C; Kelly RG; Zheng D; Scambler PJ
Cardiovasc Res; 2023 Sep; 119(11):2089-2105. PubMed ID: 37052590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
